Patient perceived changes in sexual dysfunction after initiation of natalizumab for multiple sclerosis

PURPOSE: Sexual dysfunction is a common but often overlooked secondary symptom of multiple sclerosis (MS) and can be associated with a decreased health-related quality of life (HRQoL). Natalizumab is a disease-modifying therapy approved for the treatment of relapsing forms of MS. In addition to its...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Derrick, Aungst, Angela, Collier, Ryan, Vivar, Jhulianna, Moreo, Natalie, Casady, Lise, Vu, Tuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024530/
https://www.ncbi.nlm.nih.gov/pubmed/29977589
http://dx.doi.org/10.1177/2055217318781989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024530/
https://www.ncbi.nlm.nih.gov/pubmed/29977589
http://dx.doi.org/10.1177/2055217318781989

Ejemplares similares